Activity and Safety of Tegafur, Gimeracil, and Oteracil Potassium for Nasopharyngeal Carcinoma: A Systematic Review and Meta-Analysis

Figure 3

Forest plots of the comparison of adverse reactions between the experimental (S-1 treatment) and control (non-S-1 treatment) groups. (a) Leukopenia, (b) thrombocytopenia, (c) nausea and vomiting, (d) gastrointestinal reactions, (e) diarrhea, (f) oral mucositis, (g) dermatitis, and (h) anemia.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)